Decrease of cholesterol level in plasma membrane of living HEK293 cells transiently expressing FLAG-δ-OR by β-cyclodextrin (β-CDX) resulted in a slight internalization of δ-OR. Massive internalization of δ-OR induced by specific agonist DADLE was diminished in cholesterol-depleted cells. These results suggest that agonist-induced internalization of δ-OR, which has been traditionally attributed exclusively to clathrin-mediated pathway, proceeds at least partially via membrane domains. Identification of internalized pools of FLAG-δ-OR by colocalization studies with proteins of Rab family indicated the decreased presence of receptors in early endosomes (Rab5), late endosomes and lysosomes (Rab7) and fast recycling vesicles (Rab4). Slow type of recycling (Rab11) was unchanged by cholesterol depletion. As expected, agonist-induced internalization of oxytocin receptors was totally suppressed in β-CDX-treated cells. Determination of average fluorescence lifetime of TMA-DPH, the polar derivative of hydrophobic membrane probe diphenylhexatriene, in live cells by FLIM indicated a significant alteration of the overall PM structure which may be interpreted as an increased "water-accessible space" within PM area. Data obtained by studies of HEK293 cells transiently expressing FLAG-δ-OR by "antibody feeding" method were extended by analysis of the effect of cholesterol depletion on distribution of FLAG-δ-OR in sucrose density gradients prepared from HEK293 cells stably expressing FLAG-δ-OR. Major part of FLAG-δ-OR was co-localized with plasma membrane marker Na,K-ATPase and β-CDX treatment resulted in shift of PM fragments containing both FLAG-δ-OR and Na,K-ATPase to higher density. Thus, the decrease in content of the major lipid constituent of PM resulted in increased density of resulting PM fragments.

Department of Medicine and Surgery University of Milano Bicocca Monza Italy

Laboratory of Biochemistry of Membrane Receptors Department of Biomathematics Institute of Physiology of the Czech Academy of Sciences Videnska 1083 14220 Prague 4 Czech Republic

See more in PubMed

Mol Pharmacol. 2006 Apr;69(4):1421-32 PubMed

J Biol Chem. 2005 Feb 25;280(8):7135-46 PubMed

Biochemistry. 1997 Sep 9;36(36):10944-53 PubMed

Physiol Res. 2013;62(5):547-59 PubMed

Brain Res Mol Brain Res. 1999 Jun 8;69(2):171-85 PubMed

J Cell Biochem. 1999 Oct 1;75(1):64-72 PubMed

Mol Biol Cell. 1999 Apr;10(4):961-74 PubMed

J Biol Chem. 2000 Sep 29;275(39):30211-9 PubMed

J Pharmacol Exp Ther. 1998 Aug;286(2):855-62 PubMed

J Biol Chem. 1996 Aug 9;271(32):19021-4 PubMed

Naunyn Schmiedebergs Arch Pharmacol. 2014 May;387(5):487-502 PubMed

Biochem J. 2006 Aug 1;397(3):407-16 PubMed

Annu Rev Biochem. 1998;67:199-225 PubMed

J Pharmacol Exp Ther. 2000 Aug;294(2):407-12 PubMed

Nat Genet. 2000 Jun;25(2):195-200 PubMed

J Med Chem. 2011 Jan 13;54(1):382-6 PubMed

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9914-9 PubMed

Med Sci Monit. 2010 Aug;16(8):BR260-70 PubMed

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13072-7 PubMed

J Biol Chem. 2000 Apr 14;275(15):11130-40 PubMed

J Biol Chem. 2000 Jun 9;275(23):17221-4 PubMed

J Pharmacol Exp Ther. 2003 Jul;306(1):109-15 PubMed

Biochim Biophys Acta. 2015 Mar;1848(3):781-96 PubMed

Curr Opin Neurobiol. 2004 Jun;14(3):370-8 PubMed

J Clin Invest. 2002 Oct;110(7):891-8 PubMed

Biochim Biophys Acta. 2002 Aug 31;1564(2):384-92 PubMed

J Pharmacol Exp Ther. 1993 Jun;265(3):1325-7 PubMed

Psychopharmacology (Berl). 2002 Oct;164(1):42-8 PubMed

J Pharmacol Exp Ther. 2002 Jul;302(1):188-96 PubMed

Eur J Pharmacol. 1995 Nov 3;286(1):105-8 PubMed

Eur J Biochem. 1994 Mar 1;220(2):559-67 PubMed

Brain Res Bull. 1996;39(3):185-8 PubMed

Exp Physiol. 2000 Mar;85 Spec No:41S-49S PubMed

Cell. 2002 Jan 25;108(2):271-82 PubMed

Microsc Res Tech. 2004 Jan 1;63(1):58-66 PubMed

J Biol Chem. 2000 Jan 21;275(3):2191-8 PubMed

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9421-6 PubMed

J Recept Signal Transduct Res. 2007;27(5-6):335-52 PubMed

Biochemistry. 1997 Sep 9;36(36):10959-74 PubMed

Pharmacol Ther. 2013 Oct;140(1):112-20 PubMed

Trends Pharmacol Sci. 2011 Oct;32(10):581-90 PubMed

Proteome Sci. 2014 Feb 14;12(1):11 PubMed

Biochemistry. 1987 Aug 11;26(16):5121-6 PubMed

Chem Phys Lipids. 2013 Feb-Mar;167-168:62-9 PubMed

Br J Pharmacol. 2004 Sep;143(2):235-45 PubMed

J Cell Sci. 2000 Jan;113 Pt 2:183-92 PubMed

J Biol Chem. 1986 Jun 25;261(18):8175-81 PubMed

Physiol Rev. 2011 Jan;91(1):119-49 PubMed

J Biol Chem. 2001 Nov 9;276(45):42063-9 PubMed

Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12130-4 PubMed

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6775-80 PubMed

J Pharmacol Sci. 2004 Jul;95(3):374-80 PubMed

Mol Biol Cell. 2001 Mar;12(3):685-98 PubMed

Prog Neurobiol. 2002 Apr;66(5):285-306 PubMed

Mol Pharmacol. 1997 Dec;52(6):993-9 PubMed

Brain Res. 2007 Dec 12;1184:46-56 PubMed

J Biol Chem. 1996 Nov 15;271(46):29279-85 PubMed

Biochim Biophys Acta. 2011 Dec;1810(12):1220-9 PubMed

Eur J Neurosci. 2006 Feb;23(3):830-4 PubMed

Neuron. 1999 Sep;24(1):243-52 PubMed

J Microsc. 2012 Aug;247(2):119-36 PubMed

J Pharmacol Exp Ther. 2006 Jun;317(3):1295-306 PubMed

Mol Cell Biol. 1999 Nov;19(11):7289-304 PubMed

Science. 2002 Jul 26;297(5581):615-20 PubMed

Biochim Biophys Acta. 2011 Dec;1808(12):2819-29 PubMed

Biochemistry. 1987 Aug 11;26(16):5113-20 PubMed

J Biol Chem. 2000 Dec 29;275(52):41447-57 PubMed

Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17 PubMed

J Neurosci. 2010 Dec 8;30(49):16459-68 PubMed

J Pharmacol Exp Ther. 1991 Jul 1;258(1):299-303 PubMed

J Pharmacol Exp Ther. 1979 Jan;208(1):86-90 PubMed

Cell Biochem Funct. 2008 Mar-Apr;26(2):264-74 PubMed

Biochemistry. 1981 Dec 22;20(26):7333-8 PubMed

Nature. 1996 Oct 10;383(6600):535-8 PubMed

Science. 2002 Jun 7;296(5574):1821-5 PubMed

Biochemistry. 1995 Oct 24;34(42):13784-93 PubMed

Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11069-74 PubMed

Mol Pharmacol. 2002 Mar;61(3):546-53 PubMed

Biochim Biophys Acta. 1985 Dec 9;822(3-4):267-87 PubMed

Biochem Pharmacol. 2007 Feb 15;73(4):534-49 PubMed

J Biol Chem. 1996 Aug 30;271(35):21309-15 PubMed

Br J Pharmacol. 2006 Apr;147(8):864-72 PubMed

J Biol Chem. 1995 Dec 15;270(50):29732-8 PubMed

J Membr Biol. 1988 Sep;104(3):211-21 PubMed

J Biol Chem. 2000 Feb 11;275(6):4417-21 PubMed

Nature. 1997 Jun 5;387(6633):569-72 PubMed

Eur J Neurosci. 2008 May;27(10):2558-67 PubMed

J Pharmacol Exp Ther. 1990 Aug;254(2):683-9 PubMed

Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal